Latest Circulating Tumor Cell Stories
SAN DIEGO, April 16, 2015 /PRNewswire/ -- Epic Sciences announced today that its no cell left behind(TM) technology has successfully integrated single cell isolation and downstream
Separating circulating cancer cells from blood cells for diagnostic, prognostic and treatment purposes may become much easier using an acoustic separation method and an inexpensive, disposable chip, according to a team of engineers.
GERMANTOWN, Maryland, and HILDEN, Germany, March 16, 2015 /PRNewswire/ -- - Acquisition of technology from AdnaGen enables use of innovative, non-invasive
NEW YORK, March 16, 2015 /PRNewswire/ -- S&P Capital IQ (MHFI) announced today that it has commenced
SAN DIEGO, March 9, 2015 /PRNewswire/ -- Epic Sciences and The Prostate Cancer Clinical Trials Consortium (PCCTC), the leading consortium for Phase 1/2 and Phase 2 clinical trials in prostate
Circulating tumor cell analysis provides comprehensive information from a real-time liquid biopsy that could help guide treatments for metastatic prostate cancers and bladder cancers SAN
SAN DIEGO, Jan.
-- Findings Presented at 2014 San Antonio Breast Cancer Symposium (SABCS) -- SAN ANTONIO and SAN FRANCISCO, Dec.
- Growing in low tufty patches.